Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Impact of Prolonged Sport Stoppage on Knee Injuries in High School Athletes: An Ecological Study.

Journal article

Knapic H. et al, (2024), J sport rehabil, 33, 225 - 230

Higher rates of concussion following COVID-19 infection in high school athletes.

Journal article

Bullock GS. et al, (2023), Br j sports med, 57, 590 - 594

Approach to standardized drug utilization analyses in DARWIN EU©

Conference paper

Jodicke AM. et al, (2023), Pharmacoepidemiology and drug safety, 32, 37 - 38

Linking real world data to assess risk of post-acute outcomes following COVID-19 infection in England: The ECHOES national surveillance system

Conference paper

Allen H. et al, (2023), Pharmacoepidemiology and drug safety, 32, 195 - 195

LONG-TERM EFFECTS OF INTRA-ARTICULAR CORTICOSTEROID INJECTIONS AMONG KNEE OSTEOARTHRITIS PATIENTS: AN INSTRUMENTAL VARIABLE AND PROPENSITY SCORE ANALYSIS

Conference paper

Hawley S. et al, (2023), Aging clinical and experimental research, 35, S307 - S308

Prevalence of rare blood cancers in Europe: A population-based network cohort study part of DARWIN EU®

Conference paper

Sabate MC. et al, (2023), Pharmacoepidemiology and drug safety, 32, 556 - 557

SAFETY OF INTRA-ARTICULAR CORTICOSTEROID INJECTIONS AMONG OSTEOARTHRITIS PATIENTS IN UK GENERAL PRACTICE

Conference paper

Prats-Uribe A. et al, (2023), Aging clinical and experimental research, 35, S532 - S532

Sclerostin inhibition and cardiovascular risk: Triangulating the evidence using Mendelian randomization methods

Conference paper

Alcalde-Herraiz M. et al, (2023), Pharmacoepidemiology and drug safety, 32, 462 - 463

Load More